James R. Meyers is now serving in a new position at IntraBio

Dec 05, 2020
Board and Executive Moves
Background Information
James R. Meyers
President & Chief Executive Officer at IntraBio
Career
IntraBio
Gilead Sciences, Inc.
Education
Boston College
In The News
James R. Meyers is now serving in a new position at IntraBio
Dec 05, 2020 - RelSci
Chutes & Ladders—Arena Pharma R&D chief Cabell leaves post after 6 months
Dec 04, 2020 - FierceBiotech
Gilead, looking for cancer sales, swipes Roche pharma chief Daniel O'Day for CEO post
Dec 10, 2018 - FiercePharma
IntraBio
IntraBio is a biopharmaceutical company.
In The News
James R. Meyers is now serving in a new position at IntraBio
Dec 05, 2020 - RelSci
Chutes & Ladders—Arena Pharma R&D chief Cabell leaves post after 6 months
Dec 04, 2020 - FierceBiotech
Sandhoff Disease (Jatzkewitz-Pilz Syndrome) Pipeline Review 2020 Featuring 6 Companies & 2 Drug Profiles - ResearchAndMarkets.com
Oct 13, 2020 - Business Wire
Check out News Home to stay on top of the people and organizations you care most about.
Mentioned Entities
James R. Meyers
IntraBio
Check out News Home to stay on top of the people and organizations you care most about.
Mentioned Entities
James R. Meyers
IntraBio